Sangamo Therapeutics_SGMO Shrt Term LONG Long

Sangamo Therapeutics, Inc.NASDAQ

Description

⋅ 24 déc. 2019 02:58

The stock is still in early stage of the upward recovery trajectory and has managed to overcome its purple resistance level at $8.70. Mid-term resistance at $9.95 observed,while stronger resistance at $10.70.

Plus